SeanP.DavidMDSM, DPhil, FAAFP
Family Medicine • Skokie, ILAssociate Professor of Medicine, Division of Primary Care and Population Health, Stanford University School of Medicine
Dr. David is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
9977 Woods Dr
Fl 1
Skokie, IL 60077Phone+1 224-364-2273Fax+1 847-663-8290
Education & Training
University of OxfordDPhil, Pharmacology, 2002 - 2006- Harvard School of Public HealthSM, Health and Social Behavior, 1998 - 1999
Concord Hospital/New Hampshire-Dartmouth Family MedicineResidency, Family Medicine, 1995 - 1998- Concord HospitalInternship, Transitional Year, 1995 - 1996
University of Washington School of MedicineClass of 1995- University of WashingtonBS, Zoology, 1986 - 1990
Certifications & Licensure
NH State Medical License 1998 - Present
IL State Medical License 2019 - 2026
CA State Medical License 2007 - 2025
WA State Medical License 2007 - 2012
RI State Medical License 1999 - 2010
ME State Medical License Active through 1998
VT State Medical License 1998 - 1998- American Board of Family Medicine Family Medicine
Awards, Honors, & Recognition
- James C. Puffer/American Board of Family Medicine/National Academy of Medicine Anniversary Fellowship National Academy of Medicine, 2011
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2011-2013
Clinical Trials
- Behaviorally Enhanced Counseling on Nicotine Dependence (BEACON) Trial. Start of enrollment: 2009 Jul 01
- Extended Treatment for Smoking Cessation Start of enrollment: 2010 Mar 01
Publications & Presentations
PubMed
- 144 citationsGenetic diversity fuels gene discovery for tobacco and alcohol use.Gretchen R B Saunders, Xingyan Wang, Fang Chen, Seon-Kyeong Jang, Mengzhen Liu
Nature. 2022-12-01 - 7 citationsSmoking Cessation Pharmacotherapy Based on Genetically-Informed Biomarkers: What is the Evidence?Orestis A. Panagiotou, Ewoud Schuit, Marcus R. Munafò, Derrick A Bennett, Andrew W. Bergen
Nicotine & Tobacco Research. 2019-01-25 - 50 citationsAre there sex differences in transdermal nicotine replacement therapy patch efficacy? A meta-analysisMarcus R. Munafò, Mike Bradburn, Lucy Bowes, Sean P. David
Nicotine & Tobacco Research. 2004-10-01
Press Mentions
Model-Based Assessment of Replicability for Genome-Wide Association Meta-AnalysisMarch 30th, 2021
ErratumAugust 24th, 2017
Grant Support
- Extended Treatment For Smoking CessationNational Institute On Drug Abuse2010–2011
- Exploratory/Developmental Study Of Pharmacogenetic Smoking Cessation TherapyNational Institute On Drug Abuse2009–2010
- Psychobiological /Genetic Determinants-Smoking CessationNational Institute On Drug Abuse2002–2006
- Primary Care Genetics Cancer Prevention ConferenceNational Cancer Institute2003
Other Languages
- German
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
